Skip to main content

Diagnostic options Β· UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 316–330 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5756
GJB3 Gene Deafness (DFNA2B) Genetic Test

This test evaluates the GJB3 gene for pathogenic variants associated with autosomal dominant non-syndromic hearing loss (DFNA2B) and keratoderma-deafness syndromes.

Peripheral whole blood (EDTA), dried blood spot (FTA card), or previously extracted genomic DNA 3–4 Weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["GJB3 gene sequence", "Single nucleotide variants (SNVs)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No specific medication or diet restrictions"]
Indications
["Diagnosis of autosomal dominant non-syndromic hearing loss (DFNA2B)", "Diagnosis of keratoderma-deafness syndromes", "Genetic counselling for families with GJB3-related hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: H90.3
Clinical summary
This test evaluates the GJB3 gene for pathogenic variants associated with autosomal dominant non-syndromic hearing loss (DFNA2B) and keratoderma-deafness syndromes.
TEST-5123
GJB3 Gene Erythrokeratodermia Variabilis et Progressiva Genetic Test

This test identifies pathogenic variants in the GJB3 gene associated with Erythrokeratodermia Variabilis et Progressiva (EKVP).

Whole blood (EDTA), extracted DNA, or dried blood spot on FTA card 21–28 calendar days from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["GJB3 gene coding region", "GJB3 gene splice-site coverage"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling session.", "Provide previous genetic testing reports and complete family history."]
Indications
["Suspected Erythrokeratodermia Variabilis et Progressiva (EKVP)", "Family cascade screening for EKVP"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95209-3 ICD-10: Q80.8
Clinical summary
This test identifies pathogenic variants in the GJB3 gene associated with Erythrokeratodermia Variabilis et Progressiva (EKVP).
TEST-4013
GLA Gene Fabry Disease Genetic Test

This test evaluates the GLA gene for mutations associated with Fabry disease using Next-Generation Sequencing (NGS) with Copy Number Variation (CNV) detection.

Whole blood (EDTA), Extracted DNA, or FTA Card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Alpha-galactosidase A (GLA) gene sequence", "Copy number variations (CNVs) in the GLA gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected Fabry disease based on clinical symptoms", "Family history of Fabry disease", "Carrier screening in at-risk females", "Confirmation of borderline enzyme results"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21687-4 ICD-10: E75.21, Z15.89, Z84.89
Clinical summary
This test evaluates the GLA gene for mutations associated with Fabry disease using Next-Generation Sequencing (NGS) with Copy Number Variation (CNV) detection.
TEST-4556
GLB1 Gene GM1-Gangliosidosis Genetic Test

This genetic test identifies pathogenic variants in the GLB1 gene associated with GM1-gangliosidosis.

Blood, Extracted DNA, or FTA DNA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GLB1 gene", "Point mutations", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
["No special preparation required", "Genetic counselling session recommended before sample collection"]
Indications
["Diagnosis of GM1-gangliosidosis", "Carrier screening for GM1-gangliosidosis", "Personalized management of GM1-gangliosidosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81313-7 ICD-10: E75.0
Clinical summary
This genetic test identifies pathogenic variants in the GLB1 gene associated with GM1-gangliosidosis.
TEST-3793
GLDC Gene Glycine Encephalopathy Genetic Test

This test identifies pathogenic variants in the GLDC gene, which are responsible for causing glycine encephalopathy (nonketotic hyperglycinemia). It is a targeted next-generation s...

Whole blood (EDTA) or buccal swab 21 working days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in GLDC gene coding regions", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Clinical suspicion of nonketotic hyperglycinemia", "Family history of glycine encephalopathy", "Abnormal newborn screening results", "Need for definitive molecular diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83084-7 ICD-10: E72.21
Clinical summary
This test identifies pathogenic variants in the GLDC gene, which are responsible for causing glycine encephalopathy (nonketotic hyperglycinemia). It is a targeted next-generation sequencing assay.
TEST-2449
GLI3 Gene Pallister-Hall Syndrome Genetic Test

This test identifies pathogenic variants in the GLI3 gene associated with Pallister-Hall syndrome.

Whole Blood, Extracted DNA, or Dried Blood Spot 3–4 Weeks (21–28 business days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GLI3 gene", "Likely pathogenic variants in the GLI3 gene"]
Parameters
[]
Preparation
["No fasting or special dietary preparation required", "Pre-test genetic counseling session mandatory", "Clinical history form completion by referring physician", "Legal guardian consent mandatory for minors"]
Indications
["Clinical suspicion of Pallister-Hall syndrome", "Documented family history of GLI3-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: Q87.8
Clinical summary
This test identifies pathogenic variants in the GLI3 gene associated with Pallister-Hall syndrome.
TEST-4535
GLRA1 Gene Hyperekplexia Genetic Test

This test analyzes the GLRA1 gene for mutations associated with hereditary hyperekplexia, also known as startle disease.

Peripheral whole blood (EDTA tube) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GLRA1 gene coding regions", "GLRA1 gene splice sites", "Copy number variants in GLRA1"]
Parameters
[]
Preparation
["Mandatory genetic counselling session with pedigree chart documentation", "Clinical history of the proband and affected relatives must be provided"]
Indications
["Clinical suspicion of hyperekplexia", "Family history of hyperekplexia", "Reproductive risk assessment for hyperekplexia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 78948-8 ICD-10: G25.8
Clinical summary
This test analyzes the GLRA1 gene for mutations associated with hereditary hyperekplexia, also known as startle disease.
TEST-1551
Glucose-6-Phosphate Dehydrogenase (G6PD) Full Length Gene Sequence Analysis Test

This test sequences the entire G6PD gene to identify pathogenic variants causing enzyme deficiency.

Peripheral Whole Blood, Amniotic Fluid, or Cord Blood 2–3 weeks 5,000.00 AED
View
View test specifications and preparation
What it measures
["G6PD gene sequence", "Pathogenic variants"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent blood transfusions"]
Indications
["Individuals with a family history of G6PD deficiency", "Unexplained hemolytic episodes", "Neonatal jaundice", "Individuals of African, Mediterranean, or Southeast Asian descent", "Prenatal testing for at-risk pregnancies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21626-1 ICD-10: D55.0, Z13.79
Clinical summary
This test sequences the entire G6PD gene to identify pathogenic variants causing enzyme deficiency.
TEST-3988
GNA13 Genetic Testing for Vascular System Defects Test

This test detects pathogenic variants in the GNA13 gene associated with congenital vascular malformations and related circulatory defects.

Whole blood, FTA card, or previously extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GNA13 gene"]
Parameters
[]
Preparation
["No fasting or special preparation required"]
Indications
["Family history of vascular malformations or aneurysms", "Clinical suspicion of GNA13-related vascular disorder"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101581-3 ICD-10: Q27.8, Z13.79, Z84.89
Clinical summary
This test detects pathogenic variants in the GNA13 gene associated with congenital vascular malformations and related circulatory defects.
TEST-3094
GNAI3 Gene Auriculocondylar Syndrome Type 1 Genetic Test

This test identifies pathogenic variants in the GNAI3 gene associated with Autosomal Dominant Auriculocondylar Syndrome Type 1 (ACS1).

Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GNAI3 gene pathogenic variants", "Copy Number Variations (CNV) in GNAI3"]
Parameters
[]
Preparation
[]
Indications
["Clinical suspicion of Auriculocondylar Syndrome Type 1 (ACS1)", "Family members of a confirmed proband for cascade testing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81221-0 ICD-10: Q18.8
Clinical summary
This test identifies pathogenic variants in the GNAI3 gene associated with Autosomal Dominant Auriculocondylar Syndrome Type 1 (ACS1).
TEST-4551
GNE Gene Inclusion Body Myopathy Genetic Test

This test evaluates the GNE gene for pathogenic variants associated with GNE Myopathy (Nonaka Myopathy), a hereditary neuromuscular disorder.

Whole Blood (EDTA tube) or Dried Blood Spot (FTA card) 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GNE gene", "Single-nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Splice-Site Variants"]
Parameters
[{"name": "Diagnostic Precision", "reference_range": ">99.9% β€” Full gene coverage with 100x mean depth"}, {"name": "Methodology", "reference_range": "NGS (Next Generation Sequencing) + Orthogonal Sanger Confirmation"}, {"name": "Variant Detection", "reference_range": "SNVs, Indels, Splice-Site Variants β€” Full Coding Region"}]
Preparation
["No fasting required", "Continue all prescribed medications unless instructed otherwise by your neurologist"]
Indications
["Clinical suspicion of GNE Myopathy (Nonaka Myopathy)", "Family history of GNE Myopathy", "Differential diagnosis of hereditary myopathies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21665-7 ICD-10: G71.0
Clinical summary
This test evaluates the GNE gene for pathogenic variants associated with GNE Myopathy (Nonaka Myopathy), a hereditary neuromuscular disorder.
TEST-3714
GNRHR Gene Hypogonadotropic Hypogonadism Type 7 with or without Anosmia Genetic Test

This genetic test detects pathogenic variants in the GNRHR gene associated with hypogonadotropic hypogonadism type 7.

Whole Blood, Extracted DNA, or FTA Card Dried Blood Spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GNRHR gene", "Single nucleotide variants", "Small insertions or deletions"]
Parameters
[]
Preparation
["No fasting required", "Genetic counseling session mandatory prior to testing"]
Indications
["Diagnosis of hypogonadotropic hypogonadism type 7", "Family cascade screening", "Fertility planning", "Confirmation of clinical suspicion"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82378-6 ICD-10: E23.0, R41.0
Clinical summary
This genetic test detects pathogenic variants in the GNRHR gene associated with hypogonadotropic hypogonadism type 7.
TEST-5689
GPC3 Gene Simpson-Golabi-Behmel Syndrome Type 1 Genetic Test

This test evaluates the GPC3 gene for pathogenic variants associated with Simpson-Golabi-Behmel syndrome type 1.

Peripheral blood (Whole blood in EDTA tube) 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GPC3 gene"]
Parameters
[]
Preparation
["No fasting required", "Inform phlebotomist about anticoagulant medications"]
Indications
["Suspected Simpson-Golabi-Behmel syndrome type 1", "Family history of Simpson-Golabi-Behmel syndrome type 1", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 90900-1 ICD-10: Q87.89
Clinical summary
This test evaluates the GPC3 gene for pathogenic variants associated with Simpson-Golabi-Behmel syndrome type 1.
TEST-6228
GPI Gene Hemolytic Anemia, Nonspherocytic, Due to Glucose Phosphate Isomerase Deficiency Genetic Test

This test identifies pathogenic variants in the GPI gene associated with glucose phosphate isomerase deficiency, a cause of chronic nonspherocytic hemolytic anemia.

Blood, Extracted DNA, or Dried Blood Spot (FTA Card) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GPI gene", "Exon-level copy number variants"]
Parameters
[]
Preparation
["No special preparation like fasting is required", "Pre-test genetic counseling session recommended"]
Indications
["Diagnosis of glucose phosphate isomerase deficiency", "Differentiation from other enzymopathies", "Family planning and genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: D55.8
Clinical summary
This test identifies pathogenic variants in the GPI gene associated with glucose phosphate isomerase deficiency, a cause of chronic nonspherocytic hemolytic anemia.
TEST-1918
GREM1 Gene Polyposis Syndrome, Hereditary Mixed Genetic Test

This molecular diagnostic assay detects germline mutations in the GREM1 gene associated with hereditary mixed polyposis syndrome (HMPS) and elevated colorectal cancer risk.

Whole Blood (EDTA) or Saliva (Oragene DNA collection kit) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GREM1 gene mutations", "Pathogenic variants", "Deletions", "Duplications"]
Parameters
[]
Preparation
["No special preparation required", "Provide a complete three-generation family history of colorectal cancer and polyposis"]
Indications
["Individuals with a personal or family history suggestive of hereditary colorectal cancer syndromes", "Risk stratification for colorectal cancer"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93940-4 ICD-10: Z15.09
Clinical summary
This molecular diagnostic assay detects germline mutations in the GREM1 gene associated with hereditary mixed polyposis syndrome (HMPS) and elevated colorectal cancer risk.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certaintyβ€”book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.